Clinical Trial Update: Lenalidomide In Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial of lenalidomide in patients with acute myeloid leukemia that has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED